Meera Patel, MD
Obstetrics & Gynecology · Saint Louis, MONPI 1427120948
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 240 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 17.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,061 and has fallen 88.2% since, to $125 in 2025.
Across 240 payments — averaging $16.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$666
- Mayne Pharma Commercial LLC$441
- Evofem Biosciences, Inc.$306
- Organon$281
- Bayer$249
- Pfizer$210
- plus $2K from 28 others
What the payments were for
- Food & beverage$3,910100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 41 | $666 |
| Mayne Pharma Commercial LLC | 29 | $441 |
| Evofem Biosciences, Inc. | 16 | $306 |
| Organon | 20 | $281 |
| Bayer | 15 | $249 |
| Pfizer | 14 | $210 |
| Agile Therapeutics, Inc. | 12 | $190 |
| Myovant Sciences Inc. | 10 | $182 |
| Sumitomo Pharma America, Inc. | 10 | $171 |
| Astellas Pharma US Inc | 9 | $159 |
| Coopersurgical, Inc. | 6 | $138 |
| Avion Pharmaceuticals | 7 | $103 |
| Exeltis, USA Inc. | 6 | $101 |
| Biohaven Pharmaceuticals, Inc. | 5 | $89 |
| Merck | 6 | $80 |
| Therapeuticsmd, Inc. | 6 | $79 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $61 |
| Exact Sciences | 2 | $44 |
| Hologic Sales And Service, LLC | 3 | $44 |
| Amgen | 2 | $38 |
| Johnson & Johnson | 1 | $37 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $37 |
| KCI USA, Inc. | 1 | $25 |
| Urovant Sciences Inc | 2 | $24 |
| Mission Pharmacal Company | 1 | $20 |
| Novo Nordisk | 1 | $18 |
| BD | 1 | $17 |
| Shield Therapeutics Inc | 1 | $16 |
| Optumhealth Care Solutions, LLC | 1 | $16 |
| Medtronic | 1 | $16 |
| Sage Therapeutics, LLC | 1 | $15 |
| Meditrina | 2 | $13 |
| Medicem Inc. | 1 | $13 |
| Daiichi Sankyo Inc. | 1 | $11 |
How this compares
$3,910 in reported general payments places this provider in the 85th percentile of 750 obstetrics & gynecology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremarinEstrogens, Conjugated | 16 | $7,566 |
| ImvexxyEstradiol | 17 | $5,509 |
| Estradiol | 81 | $4,831 |
| ValtrexValacyclovir Hcl | 11 | $4,433 |
| ValacyclovirValacyclovir Hcl | 25 | $684 |
| Aurovela 24 FeNorethindrone-E.Estradiol-Iron | 11 | $622 |
| Solifenacin Succinate | 13 | $528 |
| Alendronate Sodium | 44 | $236 |
| ProgesteroneProgesterone, Micronized | 11 | $88 |
| Citalopram HbrCitalopram Hydrobromide | 14 | $52 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPremarin | $210 | $7,56616 claims |
| Therapeuticsmd, Inc.Imvexxy | $79 | $5,50917 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 750 obstetrics & gynecology providers in Missouri.
Other obstetrics & gynecology in Saint Louis
- Becky LynnSaint Louis$231K
- Kimberly LemoineSaint Louis$30K
- Kaci DurbinSaint Louis$14K
- Wendi CarnsSaint Louis$14K
- Melissa TepeSaint Louis$11K
- Makeba WilliamsSaint Louis$10K
- David WeinsteinSaint Louis$10K
- Jill ScherbelSaint Louis$9K
- Jennifer SmithSaint Louis$8K
- Juliana VerticchioSaint Louis$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.